标题
Computational immunogenomic approaches to predict response to cancer immunotherapies
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1038/s41571-023-00830-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The emerging roles of γδ T cells in cancer immunotherapy
- (2023) Sofia Mensurado et al. Nature Reviews Clinical Oncology
- Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study
- (2023) Olajumoke A. Olateju et al. Frontiers in Oncology
- Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements
- (2023) Marianne Burbage et al. Science Immunology
- Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer
- (2023) Antonela Merlotti et al. Science Immunology
- Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
- (2023) Joy A. Pai et al. CANCER CELL
- Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
- (2023) Katie M. Campbell et al. CANCER CELL
- Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201/KEYNOTE-942 trial.
- (2023) Adnan Khattak et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic–transcriptomic evolution in lung cancer and metastasis
- (2023) Carlos Martínez-Ruiz et al. NATURE
- Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
- (2023) Luis A. Rojas et al. NATURE
- The evolution of lung cancer and impact of subclonal selection in TRACERx
- (2023) Alexander M. Frankell et al. NATURE
- Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements
- (2023) Nakul M. Shah et al. NATURE GENETICS
- Comparison of transformations for single-cell RNA-seq data
- (2023) Constantin Ahlmann-Eltze et al. NATURE METHODS
- Best practices for single-cell analysis across modalities
- (2023) Lukas Heumos et al. NATURE REVIEWS GENETICS
- Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
- (2023) Sapna P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing
- (2023) Yang Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response
- (2023) Wojciech Barczak et al. Nature Communications
- Benchmarking integration of single-cell differential expression
- (2023) Hai C. T. Nguyen et al. Nature Communications
- Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
- (2023) Marjan M. Naeini et al. Nature Communications
- Identification of shared characteristics in tumor-infiltrating T cells across 15 cancers
- (2023) Xiyun Jin et al. Molecular Therapy-Nucleic Acids
- Association of HLA diversity with the risk of 25 cancers in the UK Biobank
- (2023) Qiao-Ling Wang et al. EBioMedicine
- Computational prediction of MHC anchor locations guides neoantigen identification and prioritization
- (2023) Huiming Xia et al. Science Immunology
- Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy
- (2023) Charu Aggarwal et al. JAMA Network Open
- PUREE: accurate pan-cancer tumor purity estimation from gene expression data
- (2023) Egor Revkov et al. Communications Biology
- Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma
- (2023) Thomas M. Carroll et al. CANCER CELL
- Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures
- (2023) Khoa A. Tran et al. Nature Communications
- Single-cell multi-gene identification of somatic mutations and gene rearrangements in cancer
- (2023) Susan M Grimes et al. NAR Cancer
- MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
- (2022) Emeric Limagne et al. CANCER CELL
- T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
- (2022) Alexander X. Lozano et al. NATURE MEDICINE
- Identification of neoantigens for individualized therapeutic cancer vaccines
- (2022) Franziska Lang et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling
- (2022) Lucas A. Salas et al. Nature Communications
- Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
- (2022) Marta Łuksza et al. NATURE
- Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking
- (2022) Zhenqiu Huang et al. NATURE GENETICS
- Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
- (2022) Smita S. Chandran et al. NATURE MEDICINE
- Clinical relevance of tumour-associated macrophages
- (2022) Mikael J. Pittet et al. Nature Reviews Clinical Oncology
- Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- (2022) Rom Leidner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
- (2022) Jenette Creaney et al. Genome Medicine
- Comprehensive characterizations of immune receptor repertoire in tumors and cancer immunotherapy studies
- (2022) Li Song et al. Cancer Immunology Research
- MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer
- (2022) Julie Lecuelle et al. Journal for ImmunoTherapy of Cancer
- Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer
- (2022) Ignasius Joanito et al. NATURE GENETICS
- Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
- (2022) Biagio Ricciuti et al. JAMA Oncology
- Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels
- (2022) P. Ramarao-Milne et al. ESMO Open
- Leveraging big data of immune checkpoint blockade response identifies novel potential targets
- (2022) Y. Bareche et al. ANNALS OF ONCOLOGY
- Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy
- (2022) Sharon Grisaru-Tal et al. NATURE IMMUNOLOGY
- Netie: inferring the evolution of neoantigen–T cell interactions in tumors
- (2022) Tianshi Lu et al. NATURE METHODS
- Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
- (2022) Felicity Newell et al. Cancer Discovery
- Non-viral precision T cell receptor replacement for personalized cell therapy
- (2022) Susan P. Foy et al. NATURE
- TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
- (2021) Mansour Poorebrahim et al. CANCER GENE THERAPY
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- (2021) Kevin Litchfield et al. CELL
- Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
- (2021) Yang Liu et al. Nature Communications
- Inference and analysis of cell-cell communication using CellChat
- (2021) Suoqin Jin et al. Nature Communications
- How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy
- (2021) A. Fundytus et al. ANNALS OF ONCOLOGY
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
- (2021) Stefan C. Dentro et al. CELL
- TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data
- (2021) Li Song et al. NATURE METHODS
- Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer
- (2021) Fengying Wu et al. Nature Communications
- DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base
- (2021) Lisa M. Rooper et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Integrated analysis of multimodal single-cell data
- (2021) Yuhan Hao et al. CELL
- Using DNA sequencing data to quantify T cell fraction and therapy response
- (2021) Robert Bentham et al. NATURE
- Integrative single-cell analysis of allele-specific copy number alterations and chromatin accessibility in cancer
- (2021) Chi-Yun Wu et al. NATURE BIOTECHNOLOGY
- Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
- (2021) Wenming Xiao et al. NATURE BIOTECHNOLOGY
- High-throughput and single-cell T cell receptor sequencing technologies
- (2021) Joy A. Pai et al. NATURE METHODS
- Tutorial: guidelines for annotating single-cell transcriptomic maps using automated and manual methods
- (2021) Zoe A. Clarke et al. Nature Protocols
- The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
- (2021) Sara Valpione et al. Nature Communications
- Efficacy, Safety and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
- (2021) Kanwal Raghav et al. Cancer Discovery
- Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
- (2021) Felicity Newell et al. CANCER CELL
- Pan-cancer single-cell landscape of tumor-infiltrating T cells
- (2021) Liangtao Zheng et al. SCIENCE
- Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data
- (2021) Georgette Tanner et al. Nature Communications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- (2021) Vikrant Kumar et al. Cancer Discovery
- Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
- (2021) Se Ryeong Jang et al. JAMA Network Open
- Gut Microbiome Modulates Response to Cancer Immunotherapy
- (2020) Md Abdul Wadud Khan et al. DIGESTIVE DISEASES AND SCIENCES
- Peripheral T cell expansion predicts tumour infiltration and clinical response
- (2020) Thomas D. Wu et al. NATURE
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
- (2020) Mirjana Efremova et al. Nature Protocols
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Dissecting cellular crosstalk by sequencing physically interacting cells
- (2020) Amir Giladi et al. NATURE BIOTECHNOLOGY
- Putative cell type discovery from single-cell gene expression data
- (2020) Zhichao Miao et al. NATURE METHODS
- NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
- (2020) Birkir Reynisson et al. NUCLEIC ACIDS RESEARCH
- Accurate estimation of cell composition in bulk expression through robust integration of single-cell information
- (2020) Brandon Jew et al. Nature Communications
- Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
- (2020) Yann Kieffer et al. Cancer Discovery
- SCARLET: Single-Cell Tumor Phylogeny Inference with Copy-Number Constrained Mutation Losses
- (2020) Gryte Satas et al. Cell Systems
- Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
- (2020) Diana M Merino et al. Journal for ImmunoTherapy of Cancer
- Indigenous Genomic Databases: Pragmatic Considerations and Cultural Contexts
- (2020) Nadine Rena Caron et al. Frontiers in Public Health
- ASNEO: Identification of personalized alternative splicing based neoantigens with RNA-seq
- (2020) Zhanbing Zhang et al. Aging-US
- Investigations of sequencing data and sample type on HLA class Ia typing with different computational tools
- (2020) Jian Yi et al. BRIEFINGS IN BIOINFORMATICS
- Profiling immunoglobulin repertoires across multiple human tissues using RNA sequencing
- (2020) Igor Mandric et al. Nature Communications
- Assessing the performance of methods for copy number aberration detection from single-cell DNA sequencing data
- (2020) Xian F. Mallory et al. PLoS Computational Biology
- MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing
- (2020) Timothy J. O’Donnell et al. Cell Systems
- Deep learning–based cell composition analysis from tissue expression profiles
- (2020) Kevin Menden et al. Science Advances
- Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
- (2020) Padmanee Sharma et al. CANCER CELL
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
- (2020) Aurélien Marabelle et al. LANCET ONCOLOGY
- Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
- (2020) Anna K Nowak et al. LANCET ONCOLOGY
- Somatic mutation distributions in cancer genomes vary with three-dimensional chromatin structure
- (2020) Kadir C. Akdemir et al. NATURE GENETICS
- MARS: discovering novel cell types across heterogeneous single-cell experiments
- (2020) Maria Brbić et al. NATURE METHODS
- FastClone is a probabilistic tool for deconvoluting tumor heterogeneity in bulk-sequencing samples
- (2020) Yao Xiao et al. Nature Communications
- Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data
- (2020) Simone Zaccaria et al. Nature Communications
- Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
- (2020) Kiyomi Morita et al. Nature Communications
- Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma
- (2020) Paul Johannet et al. CLINICAL CANCER RESEARCH
- Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
- (2020) John H. Strickler et al. CLINICAL CANCER RESEARCH
- A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
- (2020) Wanqiu Chen et al. NATURE BIOTECHNOLOGY
- Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
- (2020) Satyen H. Gohil et al. Nature Reviews Clinical Oncology
- Bulk tissue cell type deconvolution with multi-subject single-cell expression reference
- (2019) Xuran Wang et al. Nature Communications
- Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
- (2019) Junfei Zhao et al. NATURE MEDICINE
- Linked-read analysis identifies mutations in single-cell DNA-sequencing data
- (2019) Craig L. Bohrson et al. NATURE GENETICS
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
- (2019) Dongxue Wang et al. Molecular Systems Biology
- Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
- (2019) Paul Nghiem et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- A comparison of single-cell trajectory inference methods
- (2019) Wouter Saelens et al. NATURE BIOTECHNOLOGY
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
- (2019) Francesca Finotello et al. Genome Medicine
- Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
- (2019) Gregor Sturm et al. BIOINFORMATICS
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
- (2019) Michael J. Duffy et al. CLINICAL CHEMISTRY
- T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
- (2019) Smita S. Chandran et al. IMMUNOLOGICAL REVIEWS
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data
- (2019) Salem Malikic et al. Nature Communications
- High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes
- (2019) Mandeep Singh et al. Nature Communications
- Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
- (2019) Heidi Harjunpää et al. Frontiers in Immunology
- LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
- (2019) Jan Attig et al. GENOME RESEARCH
- Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling
- (2019) Allen W. Zhang et al. NATURE METHODS
- Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods
- (2019) Alejandro Jiménez-Sánchez et al. CANCER RESEARCH
- Predicting HLA class II antigen presentation through integrated deep learning
- (2019) Binbin Chen et al. NATURE BIOTECHNOLOGY
- Developing neoantigen-targeted T cell–based treatments for solid tumors
- (2019) Tori N. Yamamoto et al. NATURE MEDICINE
- Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
- (2019) Diego Chowell et al. NATURE MEDICINE
- Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- (2019) Thomas Powles et al. NATURE MEDICINE
- Fast, sensitive and accurate integration of single-cell data with Harmony
- (2019) Ilya Korsunsky et al. NATURE METHODS
- Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy
- (2019) Claudia X Dominguez et al. Cancer Discovery
- RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines
- (2019) Luhui Shen et al. Scientific Reports
- Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
- (2019) Jeffrey C. Thompson et al. LUNG CANCER
- IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma
- (2019) Jason A. Carter et al. NATURE MEDICINE
- Reply to: ‘IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma’
- (2019) Noam Auslander et al. NATURE MEDICINE
- Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
- (2019) David Liu et al. NATURE MEDICINE
- CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones
- (2018) Sören Müller et al. BIOINFORMATICS
- Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics
- (2018) Kelly Street et al. BMC GENOMICS
- Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications
- (2018) Xin Xiao et al. CANCER TREATMENT REVIEWS
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
- (2018) Curtis H. Kugel et al. CLINICAL CANCER RESEARCH
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Improved methods for predicting peptide binding affinity to MHC class II molecules
- (2018) Kamilla Kjaergaard Jensen et al. IMMUNOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- BraCeR: B-cell-receptor reconstruction and clonality inference from single-cell RNA-seq
- (2018) Ida Lindeman et al. NATURE METHODS
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
- (2018) Chung-Han Lee et al. TRENDS IN IMMUNOLOGY
- High-throughput immune repertoire analysis with IGoR
- (2018) Quentin Marcou et al. Nature Communications
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Size Matters: Dissecting Key Parameters for Panel-Based Tumor Mutational Burden (TMB) Analysis
- (2018) Ivo Buchhalter et al. INTERNATIONAL JOURNAL OF CANCER
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Intron retention is a source of neoepitopes in cancer
- (2018) Alicia C Smart et al. NATURE BIOTECHNOLOGY
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Pan-cancer deconvolution of tumour composition using DNA methylation
- (2018) Ankur Chakravarthy et al. Nature Communications
- RNA editing derived epitopes function as cancer antigens to elicit immune responses
- (2018) Minying Zhang et al. Nature Communications
- Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
- (2018) Shelly Kalaora et al. Cancer Discovery
- Immune cell gene signatures for profiling the microenvironment of solid tumors
- (2018) Ajit J Nirmal et al. Cancer Immunology Research
- Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
- (2018) David Gfeller et al. Frontiers in Immunology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
- (2018) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- The Immune Epitope Database (IEDB): 2018 update
- (2018) Randi Vita et al. NUCLEIC ACIDS RESEARCH
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- (2018) Julija Hmeljak et al. Cancer Discovery
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
- (2018) Aaron S. Mansfield et al. Journal of Thoracic Oncology
- Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients
- (2018) Corentin Richard et al. CLINICAL CANCER RESEARCH
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
- (2017) Robert Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
- (2017) Evan W Alley et al. LANCET ONCOLOGY
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- (2017) Padmanee Sharma et al. LANCET ONCOLOGY
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- The problem with neoantigen prediction
- (2017) NATURE BIOTECHNOLOGY
- Accurate identification of single-nucleotide variants in whole-genome-amplified single cells
- (2017) Xiao Dong et al. NATURE METHODS
- SCENIC: single-cell regulatory network inference and clustering
- (2017) Sara Aibar et al. NATURE METHODS
- Detecting DNA cytosine methylation using nanopore sequencing
- (2017) Jared T Simpson et al. NATURE METHODS
- Single-cell mRNA quantification and differential analysis with Census
- (2017) Xiaojie Qiu et al. NATURE METHODS
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SysteMHC Atlas project
- (2017) Wenguang Shao et al. NUCLEIC ACIDS RESEARCH
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Estimation of immune cell content in tumour tissue using single-cell RNA-seq data
- (2017) Max Schelker et al. Nature Communications
- Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
- (2017) Guoliang Yang et al. Oncotarget
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
- (2017) John-William Sidhom et al. Cancer Immunology Research
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- BASIC: BCR assembly from single cells
- (2016) Stefan Canzar et al. BIOINFORMATICS
- Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL)
- (2016) Devin C. Koestler et al. BMC BIOINFORMATICS
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Comparison of exome-based HLA class I genotyping tools: identification of platform-specific genotyping errors
- (2016) Kazuma Kiyotani et al. JOURNAL OF HUMAN GENETICS
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
- (2016) Takuro Saito et al. NATURE MEDICINE
- Monovar: single-nucleotide variant detection in single cells
- (2016) Hamim Zafar et al. NATURE METHODS
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2016 update of the PRIDE database and its related tools
- (2016) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Gapped sequence alignment using artificial neural networks: application to the MHC class I system
- (2015) Massimo Andreatta et al. BIOINFORMATICS
- High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer
- (2015) Satu Tiainen et al. HISTOPATHOLOGY
- Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci
- (2015) Ellen W. Demerath et al. HUMAN MOLECULAR GENETICS
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Spatial reconstruction of single-cell gene expression data
- (2015) Rahul Satija et al. NATURE BIOTECHNOLOGY
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
- (2015) Tyler S. Alioto et al. Nature Communications
- Systematic pan-cancer analysis of tumour purity
- (2015) Dvir Aran et al. Nature Communications
- VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
- (2015) Mikhail Shugay et al. PLoS Computational Biology
- Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection
- (2014) Heng Zhang et al. Gastric Cancer
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
- (2014) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics
- (2014) Charles Gawad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
- (2014) Christopher A. Miller et al. PLoS Computational Biology
- Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
- (2013) D. McDermott et al. ANNALS OF ONCOLOGY
- An expression atlas of human primary cells: inference of gene function from coexpression networks
- (2013) Neil A Mabbott et al. BMC GENOMICS
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Somatic Point Mutation Calling in Low Cellularity Tumors
- (2013) Karin S. Kassahn et al. PLoS One
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- DNA methylation arrays as surrogate measures of cell mixture distribution
- (2012) Eugene Houseman et al. BMC BIOINFORMATICS
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- GenBank
- (2012) Dennis A. Benson et al. NUCLEIC ACIDS RESEARCH
- qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
- (2012) Sarah Song et al. PLoS One
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- Epigenome-wide association studies for common human diseases
- (2011) Vardhman K. Rakyan et al. NATURE REVIEWS GENETICS
- MULTIPRED2: A computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles
- (2010) Guang Lan Zhang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
- (2010) Katsuhiko Shimizu et al. Journal of Thoracic Oncology
- Direct detection of DNA methylation during single-molecule, real-time sequencing
- (2010) Benjamin A Flusberg et al. NATURE METHODS
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now